What's new in immunotherapies 2022 |
||||
|
||||
|
||||
Synopsis
Immunotherapy is a hot-topic field of research that has generated significant scientific interest and fuelled industrial innovation. Call for postersAn abstract of maximum one A4 page or 300 words indicating title and authors should be sent to This email address is being protected from spambots. You need JavaScript enabled to view it. by Monday 31 January 2022 with the subject line “What's New in Immunotherapies - poster abstract submission". Please use the template attached here. AttendeesThe event is targeted at research students, researchers, academic and industrial scientists engaged in all aspects of research into small molecule immunotherapy, and those interested in broadening their knowledge in this growing field. This event is being held back to back with "Targeting protein degradation 3 – from discovery to the clinic". ProgrammeConfirmed speakers:
In vitro assays for immunotherapy drug discovery programs; overview and emerging areas
Discovery and Development of novel Small Molecule Inhibitors of IL-17 Professor Edward Tate, Imperial College
Enabling natural killer cell immunotherapy of cancer with small molecules
|
||||
Location : London - UK Contact : SCI |